Spinal Muscular Atrophy Treatment Clinics in Thailand — AUD Prices

Thailand has approved two disease-modifying treatments for spinal muscular atrophy: risdiplam (Evrysdi) and gene therapy onasemnogene abeparvovec (Zolgensma). Both treatments slow the disease but are costly and not covered by public health schemes yet.

• Risdiplam (Evrysdi): Oral drug increasing survival motor neuron protein production.
• Onasemnogene abeparvovec (Zolgensma): Gene replacement therapy approved in 2023.
• Thai FDA approval: Both treatments received official approval for use.
• Access and cost: Treatments are high-priced and not included in Thailand’s Universal Health Coverage.

Bookimed Expert Insight: Thailand offers both risdiplam and Zolgensma, but the absence of price support limits access. Only specialised centres with stem cell and neurological expertise, like Vega Clinic in Bangkok, provide supportive care rather than full DMT coverage. Australian patients face very high costs in Thailand compared to regional options.

Patient Consensus: Patients say SMA care in Thailand is costly with no subsidy. Real success is rare, and many advise sticking with local Australian specialists. Experiences highlight that Thailand is not a practical choice for SMA treatment.

Zolgensma gene therapy is not currently available for spinal muscular atrophy treatment in Thailand. Australian patients should verify treatment options with official sources before planning travel. Leading Thai hospitals focus on other neurology treatments but do not offer Zolgensma gene therapy.

• Hospital options: Bangkok facilities specialise in neurological disorders but lack Zolgensma availability.
• Gene therapy type: Zolgensma is a one-time infusion for children with specific SMA genetic types.
• Cost and access: Therapy costs over S$2.4 million in Singapore, limiting affordability nearby.
• Trusted sources: Official medical and manufacturer information should guide treatment decisions.
• Support: Australian SMA organisations can advise on approved treatment centres abroad.

Bookimed Expert Insight: Despite Bangkok’s strong neurology services, no listed Thai clinic currently offers Zolgensma. Nearby Singapore is an approved location but with very high costs. Patients benefit by focusing on officially approved countries for gene therapy rather than assuming availability in Thailand.

Patient Consensus: Patients note Zolgensma is hugely expensive and hard to find in Southeast Asia. They stress checking with medical experts and Australian SMA groups for treatment plans. Bangkok’s hospitals are praised, but none confirm this gene therapy’s availability.

Supportive care in Thailand for spinal muscular atrophy (SMA) combines new medications with physical therapy, respiratory support, and nutrition help. Multidisciplinary teams include neurologists, physiotherapists, pulmonologists, and dietitians focused on maintaining mobility and managing breathing and swallowing. New SMA drugs like Nusinersen and gene therapy are available.

• Multidisciplinary teams: Neurologists, pulmonologists, dietitians, physiotherapists, orthopaedists.
• Physical therapy: Exercises, aquatic therapy, and stretching to maintain muscle strength.
• Respiratory support: Ventilation assistance for breathing difficulties.
• Nutritional care: Dietitians manage swallowing and nutrition challenges.
• Specialist clinics: Stem cell and regenerative medicine available at facilities like Vega Clinic.

Bookimed Expert Insight: Bangkok's Bumrungrad International Hospital offers respiratory, neurological, and nutritional care alongside SMA drugs. Clinics like Vega Clinic focus on stem cell therapy, which appeals to patients seeking complementary treatments. Patients from Australia benefit from English-speaking staff and international patient coordinators here.

Patient Consensus: Patients in Thailand stress physical therapy focused on core strength and gentle exercises. Respiratory and nutrition help are vital alongside medication. Many found local SMA groups helpful for advice and updated treatment options.

Stem cell therapies are available in Thailand for neurological conditions but are not proven for spinal muscular atrophy (SMA). Clinics in Bangkok offer mesenchymal stem cell treatments aiming to support nerve function, yet these remain experimental and are not a cure for SMA.

• Stem cell therapy types: Mesenchymal stem cells from umbilical cord or placenta.
• Key clinics: Vega Clinic in Bangkok focuses on stem cell and regenerative medicine.
• Alternative treatment role: Mainly aims to slow SMA progression, not cure it.
• Safety note: Therapy is experimental, with risks like infections or abnormal growths.
• Clinical evidence: No clear proof supports stem cell use specifically for SMA in Thailand.

Bookimed Expert Insight: Vega Clinic treats about 200 patients yearly with stem cells for various neurological issues, including children. While Thailand’s stem cell options target nerve repair, Bookimed data shows they treat spinal cord injury more than SMA. This suggests stem cell therapy for SMA remains in a clinical trial phase here, requiring caution and proper diagnosis.

Patient Consensus: Patients say stem cell treatments in Thailand focus more on spinal injuries than SMA. Many highlight the need for clear diagnosis and warn these therapies are still experimental. Some recommend proven options like physical therapy and symptom management instead.